| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Hormonothérapie
Extract
An open-label, multi-centre, uncontrolled, trial investigating degarelix one-month dosing regimen administered as intermittent androgen deprivation (IAD) for one cycle in patients with prostate cancer requiring androgen deprivation therapy.
Scientific Abstract
en cours d'intégration;